These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 21259240
21. Crystal chemistry of the antibiotic doripenem. Colombo V, Masciocchi N, Palmisano G. J Pharm Sci; 2014 Nov; 103(11):3641-3647. PubMed ID: 25231384 [Abstract] [Full Text] [Related]
22. Structural study of polymorphs and solvates of finasteride. Othman A, Evans JS, Evans IR, Harris RK, Hodgkinson P. J Pharm Sci; 2007 May; 96(5):1380-97. PubMed ID: 17455354 [Abstract] [Full Text] [Related]
24. Structural characterization of anhydrous naloxone- and naltrexone hydrochloride by high resolution laboratory X-ray powder diffraction and thermal analysis. Sugimoto K, Dinnebier RE, Zakrzewski M. J Pharm Sci; 2007 Dec; 96(12):3316-23. PubMed ID: 17582810 [Abstract] [Full Text] [Related]
25. Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine. Edwards AD, Shekunov BY, Forbes RT, Grossmann JG, York P. J Pharm Sci; 2001 Aug; 90(8):1106-14. PubMed ID: 11536215 [Abstract] [Full Text] [Related]
26. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. Lowes MM, Caira MR, Lötter AP, Van der Watt JG. J Pharm Sci; 1987 Sep; 76(9):744-52. PubMed ID: 11002813 [Abstract] [Full Text] [Related]
27. Increased dissolution rates of carbamazepine--gluconolactone binary blends processed by hot melt extrusion. Moradiya HG, Nokhodchi A, Bradley MS, Farnish R, Douroumis D. Pharm Dev Technol; 2016 Sep; 21(4):445-52. PubMed ID: 25757644 [Abstract] [Full Text] [Related]
28. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization. Maghsoodi M, Tajalli Bakhsh AS. Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665 [Abstract] [Full Text] [Related]
29. Assessment of defects and amorphous structure produced in raffinose pentahydrate upon dehydration. Bates S, Kelly RC, Ivanisevic I, Schields P, Zografi G, Newman AW. J Pharm Sci; 2007 May; 96(5):1418-33. PubMed ID: 17455351 [Abstract] [Full Text] [Related]
30. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example. Brüning J, Schmidt MU. J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117 [Abstract] [Full Text] [Related]
31. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution. Sathisaran I, Dalvi SV. AAPS PharmSciTech; 2021 Jan 06; 22(1):29. PubMed ID: 33404968 [Abstract] [Full Text] [Related]
32. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy. Tian F, Zeitler JA, Strachan CJ, Saville DJ, Gordon KC, Rades T. J Pharm Biomed Anal; 2006 Feb 13; 40(2):271-80. PubMed ID: 16146681 [Abstract] [Full Text] [Related]
33. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy. Tian F, Zhang F, Sandler N, Gordon KC, McGoverin CM, Strachan CJ, Saville DJ, Rades T. Eur J Pharm Biopharm; 2007 Jun 13; 66(3):466-74. PubMed ID: 17257816 [Abstract] [Full Text] [Related]
34. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. Li Z, Matzger AJ. Mol Pharm; 2016 Mar 07; 13(3):990-5. PubMed ID: 26837376 [Abstract] [Full Text] [Related]
35. A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam. Croker DM, Hennigan MC, Maher A, Hu Y, Ryder AG, Hodnett BK. J Pharm Biomed Anal; 2012 Apr 07; 63():80-6. PubMed ID: 22333478 [Abstract] [Full Text] [Related]
36. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug. Hu Y, Macfhionnghaile P, Caron V, Tajber L, Healy AM, Erxleben A, McArdle P. J Pharm Sci; 2013 Jan 07; 102(1):93-103. PubMed ID: 23047833 [Abstract] [Full Text] [Related]
37. Relaxation and crystallization of amorphous carbamazepine studied by terahertz pulsed spectroscopy. Zeitler JA, Taday PF, Pepper M, Rades T. J Pharm Sci; 2007 Oct 07; 96(10):2703-9. PubMed ID: 17696163 [Abstract] [Full Text] [Related]
38. Polymorphic Phase Transitions in Carbamazepine and 10,11-Dihydrocarbamazepine. Clout AE, Buanz ABM, Gaisford S, Williams GR. Chemistry; 2018 Sep 12; 24(51):13573-13581. PubMed ID: 29979477 [Abstract] [Full Text] [Related]
39. Crystal polymorphism in a carbamazepine derivative: oxcarbazepine. Lutker KM, Matzger AJ. J Pharm Sci; 2010 Feb 12; 99(2):794-803. PubMed ID: 19603503 [Abstract] [Full Text] [Related]
40. In-situ synchrotron wide-angle X-ray diffraction as a rapid method for cocrystal/salt screening. Dong P, Lin L, Li Y, Huang Z, Lang T, Wu C, Lu M. Int J Pharm; 2015 Dec 30; 496(1):107-16. PubMed ID: 25804498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]